Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe

Micro-Preemie Nyla Brooke Haywood Heads Home After 6 Months

In an inspiring display of resilience and medical marvel, Nyla Brooke Haywood, born at just 22 weeks, celebrated her departure from Silver Cross Hospital in New Lenox, Illinois, nearly six months after her birth. Dubbed a “miracle baby,” Nyla’s journey has captivated the hearts of hospital staff, friends, and family, collectively known as “Nyla Nation.” Her send-off party was a joyous occasion, marking a significant milestone in her incredible journey of growth and recovery. As Nyla heads home for the first time, her story continues to inspire and uplift all who have followed her progress.

PrevPreviousBullied Student Receives VIP Police Tour in NYC
NextSanta Fe Alumnus Reunited with Class Ring After 30 YearsNext

Recent Articles

Happy News

Scientists Just Proved That Your Brain Can Dream While You Are Wide Awake

May 11, 2026

A study from the Paris Brain Institute, published in Cell Reports, has overturned something most people take for granted: that dreaming and waking are two cleanly separate mental states, each with their own type of thoughts. Researchers monitored 92 adults using EEG caps as they drifted into and out of

Read More
Happy News

A Kitten Found Covered Head To Tail In Industrial Glue Just Made A Full Recovery And Has A New Home

May 11, 2026

When a good Samaritan in Fort Worth, Texas, discovered a small kitten stuck in a bucket of industrial-strength glue near an industrial area in April and rushed him to the Humane Society of North Texas, shelter staff were not sure the tiny animal would survive the night. The glue was

Read More
Happy News

The FDA Just Gave Pancreatic Cancer Patients Early Access To A Pill That Doubled Survival Time

May 11, 2026

The Food and Drug Administration has authorized early expanded access to a new pill called daraxonrasib, developed by Revolution Medicines, giving patients with advanced pancreatic cancer a chance to receive the experimental treatment while it awaits full regulatory approval, in a move the agency completed just two days after receiving

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.